Home LiteratureArticle Details
PMID: 15184202 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia.

American journal of respiratory and critical care medicine ·Vol. 170 ·No. 9 ·2004-11-01 ·Pages 1006-13

Mourani PM, Ivy DD, Gao D, Abman SH

Abstract

Pulmonary hypertension contributes significantly to morbidity and mortality in bronchopulmonary dysplasia (BPD), but little is known about the relative contribution of arterial tone, structural remodeling, and vessel density to pulmonary hypertension, especially in older patients. To determine the role of high pulmonary vascular tone in pulmonary hypertension, we studied the acute effects of oxygen tension, inhaled nitric oxide (iNO), and calcium channel blockers (CCB) in 10 patients with BPD who underwent cardiac catheterization for evaluation of pulmonary hypertension. During normoxic conditions, mean pulmonary arterial pressure (PAP) and pulmonary to systemic vascular resistance ratio (PVR/SVR) were 34 +/- 3 mm Hg and 0.42 +/- 0.07, respectively. In response to hypoxia, PAP and PVR/SVR increased by 50 +/- 8% and 82 +/- 14%, respectively (p < 0.01). Hyperoxia decreased PVR/SVR by 28 +/- 9% (p = 0.05). The addition of iNO treatment (20-40 ppm) to hyperoxia decreased PAP and PVR/SVR by 29 +/- 5% (p < 0.01) and 45 +/- 6% (p < 0.05) from baseline values, respectively, achieving near normal values. CCB did not alter PAP or PVR/SVR from baseline values. We conclude that hyperoxia plus iNO causes marked pulmonary vasodilatation in older patients with BPD, suggesting that heightened pulmonary vascular tone contributes to pulmonary vascular disease in BPD.

MeSH Terms
Administration, Inhalation Bronchopulmonary Dysplasia/diagnosis,drug therapy,mortality Cohort Studies Female Humans Hyperoxia/physiopathology Hypertension, Pulmonary/diagnosis,drug therapy,mortality Hypoxia/physiopathology Infant, Newborn Male Multivariate Analysis Nitric Oxide/administration & dosage Oxygen/therapeutic use Probability Prognosis Pulmonary Circulation/drug effects Respiratory Function Tests Retrospective Studies Risk Assessment Severity of Illness Index Survival Rate Treatment Outcome Vascular Resistance/drug effects
Chemicals
Nitric Oxide Oxygen
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Mourani Peter M
Division of Critical Care, The Pediatric Heart-Lung Center, Department of Pediatrics, The Children's Hospital, Denver, Colorado 80218, USA. [email protected]
Ivy D Dunbar
Gao Dexiang
Abman Steven H
Article Info
Journal
American journal of respiratory and critical care medicine
Abbr.
Am J Respir Crit Care Med
ISSN
1073-449X
Published
2004-11-01
Epub
2004-00-07
Pages
1006-13
Language
English
Region
United States
NLM ID
9421642
Subset
IM
Grants
NCRR NIH HHS · M01 RR000069 · United States
NCRR NIH HHS · M01 RR000069-457038 · United States
NHLBI NIH HHS · HL57144 · United States
NCRR NIH HHS · M01-RR00069 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]